Research findings: In conjunction with researchers at Roche and the National Taiwan University Hospital and College of Medicine in Taipei, the conclusions of the study demonstrated that LungFlag™ was able to work on Taiwanese EMR data and presented superiority over criteria based selection of individuals (USPSTF) and performed better than gold standard benchmark risk model PLCOm2012 that was adapted to be used on EMR data. The results were comparable to the previous validation studies and indicates that LungFlag™ can immediately support Taiwan screening program in identifying elevated risk populations among ever-smokers and potentially also on never-smokers populations.

Predicta Med’s data-driven insights platform, PredictAITM, aims to improve the quality of care for patients with immune-related conditions and reduce healthcare costs by assisting health professionals to identify these diseases in advance of current standards. The EMR-integrated solution can assist providers in identifying individuals with undiagnosed immune-related conditions and enabling targeted interventions earlier in the course of the disease to help mitigate disease-related deterioration and complications.

To date, the models have been trained and validated on more than 7M electronic medical

patient records and 1.7M claims records

Predicta Med is transforming the care of autoimmune diseases by offering an EMR-integrated platform that accelerates diagnosis and intervention. The platform includes three core modules:

• PredictaAI: The first AI-driven solution designed for early detection and tailored intervention of autoimmune diseases, enhancing diagnostic accuracy and speed.
• PredictaChart: The tool streamlines clinical decision-making, significantly reducing the time spent on patient chart reviews.
• PredictaMatch: A patient eligibility assessment tool, seamlessly embedded in EMRs, providing healthcare providers with relevant treatment options based on a patient’s disease profile.

Together, these modules enable faster, more accurate care decisions, improving outcomes for patients with autoimmune diseases

Predictive diagnostics using AI - Using patient data to anticipate immune-related potential health risks and improve patient care.

Effective intervention- Eenabling targeted interventions earlier in the course of the disease to help mitigate disease-related deterioration and complications.

Trained & validated on proprietary, large data sets

Domain expertise in immune-related diseases and specialty care 

Established partnerships with global experts providers

Seamless EMR workflow integration